Monoclonal Antibody Targeting Interleukin-6 Achieves Sustained Reductions in Inflammation Biomarkers Through Six Months
Munich, Germany, Aug 31: The investigational anti-interleukin-6 monoclonal antibody pacibekitug produced sustained reductions in inflammation-related biomarkers through six months in…
